MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

Detalles Bibliográficos
Autores principales: de la Puente, P, Muz, B, Jin, A, Azab, F, Luderer, M, Salama, N N, Azab, A K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771970/
https://www.ncbi.nlm.nih.gov/pubmed/26918363
http://dx.doi.org/10.1038/bcj.2016.7
_version_ 1782418478841462784
author de la Puente, P
Muz, B
Jin, A
Azab, F
Luderer, M
Salama, N N
Azab, A K
author_facet de la Puente, P
Muz, B
Jin, A
Azab, F
Luderer, M
Salama, N N
Azab, A K
author_sort de la Puente, P
collection PubMed
description
format Online
Article
Text
id pubmed-4771970
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47719702016-03-09 MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma de la Puente, P Muz, B Jin, A Azab, F Luderer, M Salama, N N Azab, A K Blood Cancer J Letter to the Editor Nature Publishing Group 2016-02 2016-02-26 /pmc/articles/PMC4771970/ /pubmed/26918363 http://dx.doi.org/10.1038/bcj.2016.7 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
de la Puente, P
Muz, B
Jin, A
Azab, F
Luderer, M
Salama, N N
Azab, A K
MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
title MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
title_full MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
title_fullStr MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
title_full_unstemmed MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
title_short MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
title_sort mek inhibitor, tak-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4771970/
https://www.ncbi.nlm.nih.gov/pubmed/26918363
http://dx.doi.org/10.1038/bcj.2016.7
work_keys_str_mv AT delapuentep mekinhibitortak733reducesproliferationaffectscellcycleandapoptosisandsynergizeswithothertargetedtherapiesinmultiplemyeloma
AT muzb mekinhibitortak733reducesproliferationaffectscellcycleandapoptosisandsynergizeswithothertargetedtherapiesinmultiplemyeloma
AT jina mekinhibitortak733reducesproliferationaffectscellcycleandapoptosisandsynergizeswithothertargetedtherapiesinmultiplemyeloma
AT azabf mekinhibitortak733reducesproliferationaffectscellcycleandapoptosisandsynergizeswithothertargetedtherapiesinmultiplemyeloma
AT ludererm mekinhibitortak733reducesproliferationaffectscellcycleandapoptosisandsynergizeswithothertargetedtherapiesinmultiplemyeloma
AT salamann mekinhibitortak733reducesproliferationaffectscellcycleandapoptosisandsynergizeswithothertargetedtherapiesinmultiplemyeloma
AT azabak mekinhibitortak733reducesproliferationaffectscellcycleandapoptosisandsynergizeswithothertargetedtherapiesinmultiplemyeloma

Ejemplares similares